Log In
Print
BCIQ
Print
Print this Print this
 

vercirnon (Traficet-EN) (GSK1605786) (formerly CCX282-B)

Also known as: 1605786, GSK786

  Manage Alerts
Collapse Summary General Information
Company ChemoCentryx Inc.
DescriptionCC chemokine receptor 9 (CCR9) antagonist
Molecular Target CC chemokine receptor 9 (CCR9) (CDw199)
Mechanism of ActionCC chemokine receptor 9 (CCR9) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationCrohn's disease
Indication DetailsTreat Crohn's disease (CD); Treat moderate to severe Crohn's disease (CD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today